Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Akso Health (AHG) Long-Term Investments (2017 - 2025)

Akso Health (AHG) has disclosed Long-Term Investments for 6 consecutive years, with $141.5 million as the latest value for Q1 2024.

  • For the quarter ending Q1 2024, Long-Term Investments changed N/A year-over-year to $141.5 million, compared with a TTM value of $141.5 million through Mar 2024, changed N/A, and an annual FY2024 reading of $141.5 million, changed N/A over the prior year.
  • Long-Term Investments was $141.5 million for Q1 2024 at Akso Health, up from $14.3 million in the prior quarter.
  • Across five years, Long-Term Investments topped out at $141.5 million in Q1 2024 and bottomed at $1.6 million in Q1 2020.
  • Average Long-Term Investments over 4 years is $47.0 million, with a median of $22.6 million recorded in 2021.
  • The sharpest move saw Long-Term Investments tumbled 94.8% in 2020, then skyrocketed 1824.61% in 2021.
  • Year by year, Long-Term Investments stood at $1.6 million in 2020, then surged by 1824.61% to $30.8 million in 2021, then plummeted by 53.45% to $14.3 million in 2022, then surged by 886.86% to $141.5 million in 2024.
  • Business Quant data shows Long-Term Investments for AHG at $141.5 million in Q1 2024, $14.3 million in Q1 2022, and $30.8 million in Q1 2021.